Zeng M, Zhang Q, Ke F
Int J Mol Sci. 2025; 26(4).
PMID: 40004028
PMC: 11855584.
DOI: 10.3390/ijms26041554.
Baca C, Marraffini L
Mol Cell. 2025; 85(2):309-322.
PMID: 39824170
PMC: 11750177.
DOI: 10.1016/j.molcel.2024.12.007.
Wei J, Li Y
Eng Microbiol. 2024; 3(4):100101.
PMID: 39628916
PMC: 11610974.
DOI: 10.1016/j.engmic.2023.100101.
Yu Z, Xu J, Zhang Y, She Q
Eng Microbiol. 2024; 3(4):100102.
PMID: 39628911
PMC: 11610955.
DOI: 10.1016/j.engmic.2023.100102.
Aviram N, Shilton A, Lyn N, Reis B, Brivanlou A, Marraffini L
Cell Host Microbe. 2024; 32(12):2050-2062.e6.
PMID: 39626678
PMC: 11708336.
DOI: 10.1016/j.chom.2024.11.005.
Engineered transcription-associated Cas9 targeting in eukaryotic cells.
Goldberg G, Kogenaru M, Keegan S, Haase M, Kagermazova L, Arias M
Nat Commun. 2024; 15(1):10287.
PMID: 39604381
PMC: 11603292.
DOI: 10.1038/s41467-024-54629-9.
The CRISPR-associated adenosine deaminase Cad1 converts ATP to ITP to provide antiviral immunity.
Baca C, Majumder P, Hickling J, Ye L, Teplova M, Brady S
Cell. 2024; 187(25):7183-7195.e24.
PMID: 39471810
PMC: 11645235.
DOI: 10.1016/j.cell.2024.10.002.
Selective degradation of phage RNAs by the Csm6 ribonuclease provides robust type III CRISPR immunity in Streptococcus thermophilus.
Johnson K, Garrett S, Noble-Molnar C, Elgarhi H, Woodside W, Cooper C
Nucleic Acids Res. 2024; 52(20):12549-12564.
PMID: 39360614
PMC: 11551762.
DOI: 10.1093/nar/gkae856.
Structural insight into the Csx1-Crn2 fusion self-limiting ribonuclease of type III CRISPR system.
Zhang D, Du L, Gao H, Yuan C, Lin Z
Nucleic Acids Res. 2024; 52(14):8419-8430.
PMID: 38967023
PMC: 11317161.
DOI: 10.1093/nar/gkae569.
Function of the RNA-targeting class 2 type VI CRISPR Cas system of .
Kretz J, Borner J, Friedrich T, McIntosh M, Procida-Kowalski T, Gerken F
Front Microbiol. 2024; 15:1384543.
PMID: 38741736
PMC: 11089165.
DOI: 10.3389/fmicb.2024.1384543.
Plasmid targeting and destruction by the DdmDE bacterial defence system.
Bravo J, Ramos D, Fregoso Ocampo R, Ingram C, Taylor D
Nature. 2024; 630(8018):961-967.
PMID: 38740055
PMC: 11649018.
DOI: 10.1038/s41586-024-07515-9.
DNA-targeting short Argonautes complex with effector proteins for collateral nuclease activity and bacterial population immunity.
Prostova M, Kanevskaya A, Panteleev V, Lisitskaya L, Perfilova Tugaeva K, Sluchanko N
Nat Microbiol. 2024; 9(5):1368-1381.
PMID: 38622379
DOI: 10.1038/s41564-024-01654-5.
Bacteriophages avoid autoimmunity from cognate immune systems as an intrinsic part of their life cycles.
Rostol J, Quiles-Puchalt N, Iturbe-Sanz P, Lasa I, Penades J
Nat Microbiol. 2024; 9(5):1312-1324.
PMID: 38565896
PMC: 11087260.
DOI: 10.1038/s41564-024-01661-6.
CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23.
Gruschow S, McQuarrie S, Ackermann K, McMahon S, Bode B, Gloster T
Nucleic Acids Res. 2024; 52(6):2761-2775.
PMID: 38471818
PMC: 11014256.
DOI: 10.1093/nar/gkae167.
The Cas10 nuclease activity relieves host dormancy to facilitate spacer acquisition and retention during type III-A CRISPR immunity.
Aviram N, Shilton A, Lyn N, Reis B, Brivanlou A, Marraffini L
bioRxiv. 2024; .
PMID: 38405743
PMC: 10888962.
DOI: 10.1101/2024.02.11.579731.
Retention of the RNA ends provides the molecular memory for maintaining the activation of the Csm complex.
Irmisch P, Mogila I, Samatanga B, Tamulaitis G, Seidel R
Nucleic Acids Res. 2024; 52(7):3896-3910.
PMID: 38340341
PMC: 11040160.
DOI: 10.1093/nar/gkae080.
The CRISPR effector Cam1 mediates membrane depolarization for phage defence.
Baca C, Yu Y, Rostol J, Majumder P, Patel D, Marraffini L
Nature. 2024; 625(7996):797-804.
PMID: 38200316
PMC: 10808066.
DOI: 10.1038/s41586-023-06902-y.
Molecular mechanism of allosteric activation of the CRISPR ribonuclease Csm6 by cyclic tetra-adenylate.
Du L, Zhu Q, Lin Z
EMBO J. 2024; 43(2):304-315.
PMID: 38177499
PMC: 10897365.
DOI: 10.1038/s44318-023-00017-w.
Substrate selectivity and catalytic activation of the type III CRISPR ancillary nuclease Can2.
Jungfer K, Sigg A, Jinek M
Nucleic Acids Res. 2023; 52(1):462-473.
PMID: 38033326
PMC: 10783487.
DOI: 10.1093/nar/gkad1102.
Type III CRISPR-Cas: beyond the Cas10 effector complex.
Stella G, Marraffini L
Trends Biochem Sci. 2023; 49(1):28-37.
PMID: 37949766
PMC: 10844953.
DOI: 10.1016/j.tibs.2023.10.006.